Asana Inc. reported a 10% year-over-year increase in revenue for Q4 2025, reaching $188.3 million, slightly exceeding analyst expectations of $188.15 million. The company maintains impressive ...

Asana Inc. reported a 10% year-over-year increase in revenue for Q4 2025, reaching $188.3 million, slightly exceeding analyst expectations of $188.15 million. The company maintains impressive gross ...

Although PCR-based methods comparing to cultivation and serological methods show many advantages, their disadvantages are not negligible. The disadvantages like sample preparation and DNA ...